British Journal of Haematology

Burkitt lymphoma following renal transplantation
pp. 583-583(1)
Authors: Riches, John; Naresh, Kikkeri; Reid, Alistair; Macdonald, Donald

Burkitt lymphoma presenting as posterior reversible encephalopathy syndrome secondary to hypercalcaemia
pp. 584-584(1)
Authors: Ma, Edmond S. K.; Chiu, Edmond K. W.; Fong, Gardian C. Y.; Li, Fu-Keung; Wong, Chris L. P.

Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production
pp. 585-596(12)
Authors: Nugent, Diane; McMillan, Robert; Nichol, Janet L.; Slichter, Sherrill J.

ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies
pp. 597-606(10)
Authors: Pagano, Livio; Valentini, Caterina G.; Caira, Morena; Fianchi, Luana

Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value
pp. 607-618(12)
Authors: Jardin, Fabrice; Picquenot, Jean-Michel; Parmentier, Françoise; Ruminy, Philippe; Cornic, Marie; Penther, Dominique; Bertrand, Philippe; Lanic, Hélène; Cassuto, Ophélie; Humbrecht, Catherine; Lemasle, Emilie; Wautier, Agathe; Bastard, Christian; Tilly, Hervé

Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma
pp. 619-626(8)
Authors: Jagannath, Sundar; Durie, Brian G. M.; Wolf, Jeffrey Lee; Camacho, Elber S.; Irwin, David; Lutzky, Jose; McKinley, Marti; Potts, Phyllis; Gabayan, Afshin Eli; Mazumder, Amitabha; Crowley, John; Vescio, Robert

Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival
pp. 627-636(10)
Authors: de Witte, Theo; Brand, Ronald; van Biezen, Anja; Mufti, Ghulam; Ruutu, Tapani; Finke, Jürgen; von dem Borne, Peter; Vitek, Antonin; Delforge, Michel; Alessandrino, Paolo; Harlahakis, Nicolas; Russell, Nigel; Martino, Roberto; Verdonck, Leo; Kröger, Nicholas; Niederwieser, Dietger

Influence of PI-3K/Akt pathway on Wnt signalling in regulating myeloid progenitor cell proliferation. Evidence for a role of autocrine/paracrine Wnt regulation
pp. 637-651(15)
Authors: Nteliopoulos, Georgios; Marley, Stephen B.; Gordon, Myrtle Y.

Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma
pp. 652-655(4)
Authors: Gerecitano, John; Portlock, Carol; Moskowitz, Craig; Hamlin, Paul; Straus, David; Zelenetz, Andrew D.; Zhang, Zhigang; Dumitrescu, Otilia; Sarasohn, Debra; Lin, Dorothy; Pappanicholaou, Jennifer; Cortelli, Barbara M.; Neylon, Ellen; Hamelers, Rachel; Wright, John; O'Connor, Owen A.

The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor
pp. 656-659(4)
Authors: Paoluzzi, Luca; Scotto, Luigi; Marchi, Enrica; Seshan, Venkatraman E.; O'Connor, Owen A.

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia
pp. 660-664(5)
Authors: Shanafelt, Tait D.; Byrd, John C.; LaPlant, Betsy; Zent, Clive S.; Call, Tim; Secreto, Charla; Grever, Michael R.; Lin, Thomas S.; Kay, Neil E.

RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia
pp. 665-668(4)
Authors: Schnittger, Susanne; Bacher, Ulrike; Kern, Wolfgang; Tschulik, Claudia; Weiss, Tamara; Haferlach, Claudia; Haferlach, Torsten

High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival
pp. 669-674(6)
Authors: Jacobsohn, David A.; Tse, William T.; Chaleff, Stanley; Rademaker, Alfred; Duerst, Reggie; Olszewski, Marie; Huang, Wei; Chou, Pauline M.; Kletzel, Morris

An observational study of children with sickle cell disease in Kilifi, Kenya
pp. 675-682(8)
Authors: Sadarangani, Manish; Makani, Julie; Komba, Albert N.; Ajala-Agbo, Tolu; Newton, Charles R.; Marsh, Kevin; Williams, Thomas N.

BCL2 expression in de novo Diffuse Large B-cell Lymphoma partly reflects normal differences in age distribution
pp. 683-684(2)
Authors: Thunberg, Ulf; Amini, Rose-Marie; Linderoth, Johan; Roos, Göran; Enblad, Gunilla; Berglund, Mattias

Fludarabine combinations for patients with advanced marginal zone lymphomas - best treatment option or too toxic?
pp. 685-686(2)
Authors: Peinert, Stefan; Carney, Dennis; Miles Prince, H.; Henry Januszewicz, E.; Seymour, John F.

Altered mRNA expression of PAX5 is a common event in acute lymphoblastic leukaemia
pp. 686-689(4)
Authors: Santoro, Alessandra; Bica, Maria G.; Dagnino, Lea; Agueli, Cecilia; Salemi, Domenico; Cannella, Sonia; Veltroni, Marinella; Cetica, Valentina; Giarin, Emanuela; Fabbiano, Francesco; Basso, Giuseppe; Arico, Maurizio

A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation
pp. 689-691(3)
Authors: Di Ianni, Mauro; Baldoni, Stefano; Rosati, Emanuela; Ciurnelli, Raffaella; Cavalli, Laura; Martelli, Massimo F.; Marconi, PierFrancesco; Screpanti, Isabella; Falzetti, Franca

Pregnancy and risk of venous thromboembolism in developing countries
pp. 691-692(2)
Authors: Nassar, Anwar H.; Musallam, Khaled M.; Cappellini, Maria D.; Taher, Ali T.

FLNA, a new partner gene fused to MLL in a patient with acute myelomonoblastic leukaemia
pp. 693-695(3)
Authors: De Braekeleer, Etienne; Douet-Guilbert, Nathalie; Morel, Frédéric; Le Bris, Marie-Josée; Meyer, Claus; Marschalek, Rolf; Férec, Claude; De Braekeleer, Marc

UK NEQAS for Blood Coagulation Near Patient/Point of Care INR Testing Meeting: 10^th November 2009, City Suite, Mercure St Paul's Hotel, 119 Norfolk Street, Sheffield S1 2JE
pp. 696-696(1)